Julie Aull, PA
Physician Assistant · New Albany, INNPI 1982617387
Payments from drug & device makers
Across 333 payments — averaging $16.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$409
- Takeda Pharmaceuticals U.S.A., Inc.$388
- GSK$290
- AstraZeneca$272
- Bayer$213
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,355100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 136 | $1,973 |
| Novo Nordisk | 25 | $409 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $388 |
| GSK | 16 | $290 |
| AstraZeneca | 13 | $272 |
| Bayer | 12 | $213 |
| Boehringer Ingelheim | 13 | $174 |
| Lilly USA, LLC | 8 | $147 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $141 |
| Merck | 8 | $137 |
| Amgen | 7 | $133 |
| Novartis | 8 | $130 |
| Exact Sciences | 7 | $119 |
| Johnson & Johnson | 6 | $108 |
| E.r. Squibb & Sons, L.L.C. | 7 | $107 |
| Pfizer | 7 | $106 |
| Biohaven Pharmaceuticals, Inc. | 5 | $91 |
| Antares Pharma, Inc. | 3 | $61 |
| Phathom Pharmaceuticals, Inc. | 3 | $58 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Boston Scientific | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 3 | $38 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Pulmonx Corporation | 1 | $22 |
| Agios Pharmaceuticals, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Mylan Specialty L.p. | 1 | $17 |
| Lifescan, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
How this compares
$5,355 in reported general payments places this provider in the 90th percentile of 1,955 physician assistant providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 127 | $102,564 |
| OzempicSemaglutide | 67 | $80,392 |
| EliquisApixaban | 60 | $57,051 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 55 | $36,973 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $29,219 |
| MounjaroTirzepatide | 17 | $27,050 |
| RelistorMethylnaltrexone Bromide | 11 | $25,772 |
| TrulicityDulaglutide | 19 | $22,209 |
| JanuviaSitagliptin Phosphate | 11 | $16,174 |
| FarxigaDapagliflozin Propanediol | 17 | $13,886 |
| EntrestoSacubitril/Valsartan | 13 | $13,041 |
| LinzessLinaclotide | 14 | $12,780 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $11,092 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $8,875 |
| MovantikNaloxegol Oxalate | 14 | $5,702 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $174 | $102,564127 claims |
| Novo NordiskOzempic | $409 | $80,39267 claims |
| PfizerEliquis | $106 | $57,05160 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $272 | $50,85972 claims |
| Lilly USA, LLCMounjaro, Trulicity | $147 | $49,25936 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $290 | $49,18747 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $43 | $25,77211 claims |
| MerckJanuvia | $137 | $16,17411 claims |
| AbbVieLinzess, Synthroid | $1,973 | $13,78331 claims |
| NovartisEntresto | $130 | $13,04113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,955 physician assistant providers in Indiana.
Other physician assistant in New Albany
- Stephanie MurphyNew Albany$9K
- Kristen GumpfCarmel$142K
- Andrew NordIndianapolis$47K
- Qun Ming ZhangIndianapolis$28K
- Lauren HoweMunster$28K
- A FergusonFort Wayne$22K
- Jacquelyn BeemerFort Wayne$21K
- Lindsay YoderIndianapolis$21K
- Eryn GormanClinton$18K
- Audrey HewittBloomington$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.